在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Gilead Sciences unveils campaign to help women fight cancer

By Zhong Nan | chinadaily.com.cn | Updated: 2024-03-15 16:05
Share
Share - WeChat
The booth of Gilead Sciences at the fifth China International Import Expo in Shanghai on Nov 7, 2022. [Photo/VCG]

Gilead Sciences, a research-based biopharmaceutical company from California, launched a women's health advocacy campaign in China on Wednesday built around the idea of "taking back" the possibilities that cancer causes.

Themed "Cancer steals possibility. We're taking it back", the campaign, partnered with Marie Claire, a renowned women's lifestyle and fashion media, is a part of Gilead's global oncology franchise campaign. The project unites triple-negative breast cancer patients, authoritative medical experts and influential female representatives to share their personal experiences and stories of mutual support in the fight against cancer.

Breast cancer has become the leading type of cancer worldwide, with "triple-negative breast cancer" being a particularly difficult subtype to treat. This type of disease accounts for about between 10 to 15 percent of all breast cancers, according to information released by Atlanta-based American Cancer Society.

This form of breast cancer is highly aggressive and more likely to recur and spread than other types, posing a significant challenge for patient prognosis. The five-year survival rate for individuals with advanced metastatic triple-negative breast cancer is a mere 12.2 percent.

Jin Fangqian, vice-president of Gilead Sciences and the group's general manager for China, said as an innovation-driven company, Gilead is not only committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer, but also striving to remedy health inequities and break down barriers to care.

"By launching this campaign, we hope to further raise awareness of women's health in local society, enhance public understanding of breast cancer prevention and treatment, and help patients regain the possibilities in their lives," said Jin, adding the company will continue to invest in innovative research and development in the field of breast cancer and broader cancer types.

Gilead commenced its commercial operations in China in 2017, initially on virology focusing on HIV prevention and treatment, and viral hepatitis. By 2023, the company expanded into the oncology sector, introducing a new treatment option to China for patients with inoperable locally advanced or metastatic triple-negative breast cancer, offering innovative treatment option for those affected by this challenging condition.

In response to the Health China 2030 Initiative, the company has also collaborated with governments, associations, hospitals and research institutions to bring its innovative treatments to larger patient populations.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲天堂免费在线视频 | 欧美精品亚洲精品 | 久久久一区二区三区 | 91精品国产综合久久精品 | 久久久久久影院 | 久久伦理电影 | 国产亚洲一区二区在线观看 | 天堂在线中文 | 精品国产乱码久久久久久影片 | 一呦二呦三呦国产精品 | 欧美夜夜爽 | 亚洲一区成人在线 | 国产亚洲成av人片在线观看桃 | 日韩免费福利视频 | 国产精品极品美女在线观看免费 | 国产精品久久久久久福利 | 精品综合 | 97视频观看 | 久久久久国产一区二区三区 | 91精品国产色综合久久 | 可以免费看黄视频的网站 | 手机看片福利 | 国产高清成人久久 | 国产激情毛片 | 视频1区2区 | 精品国产一区二区三区小蝌蚪 | 欧美成人福利 | 国产视频一区二区 | 亚洲综合在线一区 | 日韩色综合 | 精品亚洲一区二区三区四区五区 | 国产中文一区二区三区 | 狠狠91| 一区二区在线视频 | 成人国产精品久久久 | 中文字幕一区二区在线观看 | 国精产品一区二区三区 | 婷婷色网 | 日韩欧美在线观看一区 | 国偷自产视频一区二区久 | 中文字幕精品一区二区三区精品 |